美国基金动向（7）治部，连载，面向AMED（日本版NIH）建立新指标体系--之七

摘要

AMED（日本版NIH）及其制药企业，政策制定与战略规划需要循证。为此，本研究尝试基于新的指标体系进行制药行业的现状俯瞰与未来预测。本篇通过对不同事业主体、疾病的分析，尝试俯瞰以美国政府机构为中心的药物开发有关的基金动向。%For the sake of providing evidences that contribute to policy making or strategy planning in a Japanese version of the NIH and pharmaceutical companies, we tried an overview the funding trends for the drug development of US organizations by principles, partners, and diseases.